Skip to main content
. 2023 Oct 17;330(15):1437–1447. doi: 10.1001/jama.2023.19597

Table 2. Baseline Characteristics of Medicare Beneficiaries Entering the Model in 2017 or 2018.

Characteristic No. (%)
High-risk beneficiaries Medium-risk beneficiaries
Intervention (n = 40 423) Control (n = 27 277) Intervention (n = 90 155) Control (n = 61 009)
Demographics and socioeconomic status
Age, median (IQR), ya 75 (71-77) 75 (71-77) 71 (68-74) 71 (68-75)
Black raceb 3103 (8) 1753 (6) 7373 (8) 4047 (7)
Mena 26 434 (65) 17 833 (65) 49 202 (55) 34 176 (56)
Women 13 989 (35) 9444 (35) 40 953 (45) 26 833 (44)
Dually eligible for Medicaida 3788 (9) 2746 (10) 8675 (10) 6093 (10)
Risk factors for myocardial infarction and stroke
CVD risk score, median (IQR), percentage pointsc,d 37 (33-45) 38 (33-45) 21 (18-25) 21 (18-25)
Diabetes 25 828 (64) 17 033 (62) 24 516 (27) 16 813 (28)
Ischemic heart diseasee 15 403 (38) 10 728 (39) 26 454 (29) 19 076 (31)
Total cholesterol, median (IQR), mg/dLc 164 (140-193) 164 (139-194) 173 (148-201) 172 (147-200)
LDL cholesterol,c median (IQR), mg/dL 88 (68-113) 87 (67-113) 95 (74-119) 93 (72-118)
LDL cholesterol ≥70 mg/dL 29 195 (73) 19 553 (72) 71 983 (80) 47 777 (79)
Systolic blood pressure, median (IQR), mm Hgc 138 (128-150) 138 (128-150) 130 (121-140) 130 (122-140)
Systolic blood pressure ≥130 mm Hg 29 955 (74) 20 268 (74) 48 902 (54) 33 374 (55)
Current smokingc 5041 (12) 3951 (14) 9442 (10) 7078 (12)
Medication use
Aspirinc 20 567 (51) 13 452 (49) 38 958 (43) 24 500 (40)
Medicare Part D prescription drug coveragef 28 348 (70) 19 061 (70) 61 064 (68) 41 290 (68)
Antihypertensive usef 25 561 (90) 17 015 (89) 48 442 (79) 32 575 (79)
Statin usef 19 517 (69) 12 960 (68) 37 089 (61) 25 401 (62)
Model entryg
Initial model visit with a primary care physician 23 369 (58) 16 466 (60) 52 777 (59) 37 796 (62)
Initial model visit with a cardiologist 10 953 (27) 7470 (27) 23 801 (26) 15 867 (26)
Time from model launch to initial model visit, median (IQR), d 122 (55-265) 157 (70-297) 136 (64-282) 168 (77-307)
Health care service use in the year before model entrye
Total Medicare Parts A and B spending per beneficiary per month, median (IQR), $ 241 (98-622) 233 (93-601) 205 (80-532) 201 (77-525)
All-cause hospitalizations per 1000 people per year, mean (SD)h 204 (747) 201 (619) 181 (636) 189 (769)
CVD-specific hospitalizations per 1000 people per year, mean (SD)h 49 (309) 45 (271) 39 (272) 42 (321)
All-cause ED visits per 1000 people per year, mean (SD)h 395 (1080) 383 (969) 377 (1202) 367 (1199)
CVD-specific ED visits per 1000 people per year, mean (SD)h 32 (238) 32 (213) 28 (259) 26 (212)
Office visits per person per year, median (IQR) 8 (5-13) 8 (4-13) 7 (4-12) 7 (4-12)
Office visits per person per year with a practitioner listed on the organization’s Million Hearts Model application, median (IQR) 2 (1-4) 2 (1-4) 2 (0-3) 2 (1-4)

Abbreviations: CVD, cardiovascular disease; ED, emergency department; LDL, low-density lipoprotein.

a

Based on data from the Medicare enrollment database.

b

Based on registry data submitted by the Million Hearts Model participating organizations, validated against data in the Medicare Enrollment Database. Because CVD risk score calculation differs for those with Black race vs non-Black race,1,11 CMS required model participants only to provide race information stating whether beneficiaries were Black or not Black. However, imputed race data from the RAND Medicare Bayesian Improved Surname Geocoding race and ethnicity file—which incorporates information from the Medicare Enrollment Database as well as name and address—suggest the model population with high and medium risk was 84% non-Hispanic White, 7% non-Hispanic Black, 4% Hispanic (of any race), and 4% Other (American Indian and Alaska Native, non-Hispanic Asian and Pacific Islander, or multiracial).

c

Based on data from the Million Hearts Data Registry.

d

The CVD risk score is the predicted probability of a myocardial infarction or stroke within 10 years expressed as a percentage (0%-100%). Risk scores were calculated based on demographic information (age, sex, and race), clinical information (blood pressure and lipid levels and diabetes status), smoking status, and use of antihypertensives, following the study by Goff et al.11 The study population limits to beneficiaries with a CVD risk score of at least 15%. The maximum observed risk score was 88% for high-risk beneficiaries and just less than 30% for medium-risk beneficiaries.

e

Based on Medicare Parts A and B claims.

f

Based on Medicare Part D claims.

g

Based on Million Hearts Data Registry data linked to specialty information in the National Plan & Provider Enumeration System.

h

Mean values per 1000 people are shown rather than the median values per person because the median values per person were all 0.